A US-led team has used genome-editing technique CRISPR-Cas9 to alter immune cells to fight cancer in a mouse model. The research, which was conducted at the University of Pennsylvania’s Burnham Institute for Medical Research, was published in Nature Communications on Monday. The mice were injected with immune cells from their own bone marrow to treat…